Glenmark Pharmaceuticals’ arm launches Polyethylene Glycol 3350

10 Mar 2025 Evaluate

Glenmark Pharmaceuticals’ subsidiary--Glenmark Therapeutics Inc., USA has launched Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC); compare to the active ingredient in MiraLAX Powder for Solution, 17 grams of Bayer HealthCare LLC. Glenmark’s Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC) is only marketed for the indications listed in Glenmark’s approved drug facts label.

According to Nielsen syndicated data for the latest 52 weeks’ period ending February 22, 2025, the MiraLAX Powder for Solution, 17 grams (OTC) market achieved annual sales of approximately $555.7 million. 

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.


Glenmark Pharma Share Price

1956.40 3.50 (0.18%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×